ha14-1 has been researched along with Acute Lymphoid Leukemia in 2 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiffar, T | 1 |
| Kurinna, S | 1 |
| Suck, G | 1 |
| Carlson-Bremer, D | 1 |
| Ricciardi, MR | 1 |
| Konopleva, M | 1 |
| Andreeff, M | 1 |
| Ruvolo, PP | 1 |
| Su, Y | 1 |
| Zhang, X | 1 |
| Sinko, PJ | 1 |
2 other studies available for ha14-1 and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation.
Topics: Antineoplastic Agents, Phytogenic; Benzopyrans; Cell Cycle; Drug Resistance, Neoplasm; Enzyme Inhibi | 2004 |
Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer.
Topics: Apoptosis; Benzopyrans; Caspases; DNA Fragmentation; Drug Resistance, Multiple; Enzyme Activation; G | 2007 |